Merit Medical signals 2026 non-GAAP EPS of $4.25 to $4.35 while raising organic growth outlook to 6.9% to 7.5% (NASDAQ:MMSI)

Merit Medical signals 2026 non-GAAP EPS of $4.25 to $4.35 while raising organic growth outlook to 6.9% to 7.5% (NASDAQ:MMSI)

Merit Medical (MMSI) Q2 2026 earnings call recap: 10% revenue growth, margin expansion, tariff refund impact, and raised FY2026 EPS guidance—read now.